title: Antibiotic releasing biodegradable scaffolds for osteomyelitis.
abstract: Osteomyelitis is characterized by progressive inflammatory bone degeneration. In the management of chronic osteomyelitis, it is necessary to remove the infected bone tissue followed by implantation of an antibiotic releasing biomaterial that can release antibiotic locally for long periods of time. The main carrier used in clinics for this application is polymethylmethacrylate (PMMA) (Eg. Septopal beads). However, major drawback is the need of an additional surgery to remove the beads after therapy, as PMMA is not biodegradable. This necessitates the requirement of biodegradable carrier systems that can release antibiotics and simultaneously support debrided bone formation. This review summarizes biodegradable carrier systems that have been reported for the localised treatment and prophylaxis of osteomyelitis.
authors.forename: Manitha
authors.initials: M
authors.lastname: Nair
authors.affiliation: Amrita Center for Nanosciences and Molecular Medicine, Amrita Institute of Medical Science & Research Center, Amrita Vishwa Vidyapeetham University, Cochin, Kerala 682041, India. manithanair@aims.amrita.edu.
authors.forename: Amit
authors.initials: A
authors.lastname: Krishnan
mesh_terms: D020341:Absorbable Implants; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004337:Drug Carriers / Q000008:administration & dosage* / Q000378:metabolism*; D006801:Humans; D010019:Osteomyelitis / Q000188:drug therapy* / Q000517:prevention & control* / Q000601:surgery; D065286:Prophylactic Surgical Procedures
chemical_list: D000900:Anti-Bacterial Agents; D004337:Drug Carriers